is a life sciences industry collaborative group, supporting the UK to lead in the field of dementia treatment and research
is a life sciences industry collaborative group, supporting the UK to lead in the field of dementia treatment and research
The Dementia Industry Group seeks to engage in an open and transparent dialogue with our partner stakeholders to begin to address the needs, opportunities and challenges facing us all in tackling one of the most devastating conditions affecting our population now and in the future.
The Dementia Industry Group represents a group of life sciences companies with a global research and development spend in dementia in excess of $4 billion.
The companies collaborating in this group are committed to working together with all stakeholders to invest in the future of dementia care.
Sponsor statement:
Biogen, Eisai, InHealth, Lilly and Roche Diagnostics have provided financial support to Dementia Industry Group towards the development of this website.
Copyright © 2023 Dementia Industry Group - All Rights Reserved.